Serum digoxin concentrations during ethmozine antiarrhythmic therapy
- 1 April 1986
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 111 (4) , 667-672
- https://doi.org/10.1016/0002-8703(86)90096-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Update on the influence of quinidine and other agents on digitalis glycosidesAmerican Heart Journal, 1984
- A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexesThe American Journal of Cardiology, 1983
- Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: Documentation of efficacy and long-term safetyAmerican Heart Journal, 1983
- The influence of quinidine and other agents on digitalis glycosidesAmerican Heart Journal, 1982
- New Antiarrhythmic DrugsDrugs, 1981
- High-Performance Liquid Chromatographic Determination of Ethmozin in PlasmaJournal of Pharmaceutical Sciences, 1981
- Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation, 1980
- Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and toleranceAmerican Heart Journal, 1979
- Effectiveness of increasing hours of continuous ambulatory electrocardiography in detecting maximal ventricular ectopy: Continuous 48 hour study of patients with coronary heart disease and normal subjectsThe American Journal of Cardiology, 1978
- Effect of quinidine on plasma concentrations of digoxin.BMJ, 1978